Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fertomcidina U versus chlorhexidine in recurrent aphthous stomatitis
2007-002624-15Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in aphthosis (RAS) comparing Fertomcidina U with Chlorhexidine 0.2% (2 arms). Primary endpoints: Remission of symptoms and reduction in objective signs severity and Stability of therapeutic result over 8 weeks after treatment discontinuation. Started Jul 2007; status: active.
02
Drugs
Fertomcidina Uchlorhexidine
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on 2007-002624-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002624-15.